Institutional Review Board (IRB)
Overview of IRB
The Institutional Review Board (IRB) at Weill Cornell Medicine - Qatar reviews all human subjects’ research in which the institution is engaged.
The IRB has the authority to approve, refuse, and require modifications in all research activities that fall within its jurisdiction as specified by both federal & Qatari regulations and institutional policies.
Human Subjects Training
WCM-Q personnel engaged in human subjects research are required to complete the Collaborative Institutional Training Initiative (CITI) as per HRP-031 policy prior to their involvement in human subject research activities.
The Research Compliance office also offers training sessions for researchers to facilitate the ethical conduct of research. For more information click here.
How to Submit to the IRB
WCM-Q IRB uses IRBNet, a web-based electronic system for review of all applications. It is accessible to WCM-Q research community, IRB members & IRB staff at anytime, anywhere via www.irbnet.org.
The IRB follows written policies and procedures which are available to all WCM-Q researchers on the IRBNet Library. For guidance on what should be submitted to the IRB for review, please refer to the submission requirements for the WCM-Q IRB
Assurance & Collaborative Research
Ministry of Public Health (MoPH) Assurance:
Ministry of Public Health in Qatar (MoPH) institutional assurance and the IRB committee registration apply whenever the institution becomes engaged in human subjects research. Local/foreign Institutional Review Boards (IRB) engaged in human subjects’ research must submit an Assurance to the Department of Research of the MoPH in Qatar. Assurance Application for the Protection of Human Subjects Involved in Research
Assurance application will be submitted through the IRB office to the MoPH in Qatar.
Both WCM-Q and WMC-NY has valid assurances with MoPH
-MoPH WCM-Q assurance number: IRB-A-WCM-Q-2019-0004
-MoPH WCM-NY assurance number: MOPH-FA-WCMC-US-000213
All research involving human subjects conducted privately or governmentally supported or otherwise subject to regulation by any department of research or research organization in Qatar including research conducted or supported in collaboration with a non-Qatari institution must abide by MoPH's Policies, Regulations and Guidelines for Research Involving Humans, which outlines and provides safeguards for the ethical conduct of human research.
Office for Human Research Protections – Belmont report
MoPH in Qatar Human Research Policies & Regulations
The U.S. Food and Drug Administration regulations at 21 CFR parts 50 and 56 for clinical trails
The current International Conference on Harmonization E-6 Guidelines for Good Clinical Practice (ICH-GCP-E6)
Weill Cornell Medicine in Qatar (WCM-Q) and Hamad Medical Corporation (HMC):
WCM-Q and HMC have entered into a reliance agreement to enhance and streamline the IRB review process for collaborative research to facilitate the process without compromising ethical principles and protections for human research subjects. HRP-172 SOP Reliance Agreement details the process and requirements.
Weill Cornell Medicine - Qatar (WCM-Q) and Weill Cornell Medicine in New York (WCM-NY) Institutional Review Boards (IRBs):
WCM-NY and WCM-Q has valid Federal Wide Assurance (FWA) filed with the United States Office of Human Research Protections (OHRP). At the same time both have valid assurances with the Ministry of Public Health in Qatar. WCMC-NY and WCM-Q have written agreements to manage the regulatory oversight of research projects involving human subjects that are conducted jointly between faculty members. This agreement was initiated to facilitate collaboration and avoid the duplication of IRB reviews. WCM-Q's IRB serves as the IRB of record in most of collaborative work that takes place in Qatar. However, in some instances WCM-NY's IRB review maybe warranted. The IRB offices in Qatar & NY will guide the investigators through the process. Close coordination between both offices take place to facilitate review and shorten the turnaround time.
for more information please contact the IRB office at email@example.com
Federal wide assurance (FWA) Number: FWA00029302
IRB Meetings Calendar
IRB meeting calendar for 2020
Important Notice: Updated Documents Posted
Archived News here.
I am a research participant and need to report a concern
If you are a research participant and have a complaint about your research project or have questions about your rights as a research participant, please contact the IRB Office at firstname.lastname@example.org or call the the office on +974 44928960 from Sunday to Thursday 7:30 AM to 3:30 PM. You can also access direct contact information on our contacts page.
Your private information will remain confidential and be known only to the persons who will deal with your compliant.
To access FAQS please click here